July 2017 – Kahn Partners, counsel to Diaxonhit on its acquisition of GenBio
Kahn Partners represented Paris-based Diaxonhit in its acquisition of GenBio, a San Diego based medical diagnostic company. Diaxonhit is a company listed on Euronext in Paris. The transaction, which w...
March 2017 – Kahn Partners, counsel to Itelios on its acquisition by Capgemini
Kahn Partners advised Itelios, a consulting firm specialized in connected commerce, on the acquisition by Capgemini, a global leader in consulting, technology and outsourcing services. Itelios will...
Success for Kahn Partners annual cocktail
Kahn Partners held its 2017 annual cocktail in Paris. The evening was a success, gathering all members of Kahn Partners' team with their clients.
Kahn Partners, new member of the French American Chamber of Commerce of San Francisco
Kahn Partners just became member of the French American Chamber of Commerce of San Francisco (FACCSF). The FACCSF is a non-profit, non-governmental, 100% independent, member driven organization, ma...
Happy New Year 2017 from Kahn Partners
From all of us at Kahn Partners, we wish you a wonderful New Year filled with joy, good health and prosperity!
Kahn Partners, counsel to Mexel Industries in its sale of business to Taihaimanuer Heyuan
Kahn Partners represented Mexel Industries in the sale of its water treatment business to Shanghai-based Taihaimanuer Heyuan. The acquisition by the Chinese conglomerate involved multiple regulatory c...
Kahn Partners’ new offices in Washington D.C. and San Francisco
Kahn Partners moved its headquarters to 2200 Pennsylvania Avenue in Washington D.C., and opened a new office at 425 Market Street in San Francisco.